Characteristics and indications of gabapentin;Características e indicaciones de la gabapentina

Revista de Neurologia

Volumn 35, Issue SUPPL. 1, 2002, Pages

  Sancho Rieger, Jerónimo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Adjunctive therapy; Antiepileptic drugs; Epilepsy; Gabapentin; Mono therapy; Partial epileptic seizures

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; GABAPENTIN;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ATAXIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; EPILEPSY; FATIGUE; FOCAL EPILEPSY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROPATHIC PAIN; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SHORT SURVEY; SOMNOLENCE; SPASTICITY; VERTIGO;

ACETIC ACIDS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINES; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED;

EID: 0036764336     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Pande AC, Davidson JRT, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, et al. Treatment of social phobia with gabapentin a placebo-controlled study. J Clin Psycopharmacol 1999; 19: 341-8.
2. Backonja MM. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebocontrolled trial in patients with diabetes mellitus. Epilepsia 1999; 30 (Suppl 6): S57-9.
3. Priebe MM, Sherwood AM, Graves DE, Mueller M, Olson WH. Effectiveness of gabapentin in controlling spasticity: A quantitative study. Spinal Cord 1997; 35: 171-5.
4. Miller RG, Moore D, Youg LA. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 1996; 47: 1383-8.
5. Magnus L. Nonepileptic uses of gabapentin. Epilepsia 1999; 40 (Suppl 6): S66-72.
6. Herranz JL. Datos actuales sobre gabapentina. Rev Neurol 2000; 30 (Supl 1): 25-31.
7. Goa KL, Sorkin EM. Gabapentin. A review of the pharmacological properties and clinical potential in epilepsy. Drugs 1993; 46: 409-27.
8. Sivenius J, Kalviainen R, Ylinen A, Riekkinen P. Double-blind study of gabapentin in the treatment of partial seizures. Epilepsia 1991; 32: 539-42.
9. UK Gabapentin study group. Gabapentin in partial epilepsy. Lancet 1990; 335: 1114-7.
10. The US Gabapentin study group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled study. Neurology 1993; 43: 2292-8.
11. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B, et al. Gabapentin (neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study. Epilepsia 1994; 35: 795-801.
12. Morrell MJ. Dosing to efficacy with Neurontin: The STEPS trial. Epilepsia 1999; 40 (Suppl 6): S23-6.
13. Bruni J on behalf of the NEON Study Investigators Group. Outcome evaluation of gabapentin as add-on therapy for partial seizures. Can J Neurol Sci 1998; 25: 134-40.
14. Herranz JL, Sol JM, Hernández G, y grupo español colaborativo de gabapentina. Gabapentina asociada en 559 pacientes con epilepsias parciales. Estudio observacional multicéntrico. Rev Neurol 2000; 30: 1141-5.
15. Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology 1998; 51: 1282-8.
16. Bergey GK, Morris HH, Rosenfeld W, Blume WT, Penovich PE, Morell MJ, et al. Gabapentin monotherapy. I. An 8-day, double-blind, dose-controlled. Multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. Neurology 1997; 49: 739-45.
17. Brodie MJ, Anhut H, Murray G, Maton S, and the 945-212 Study Group. Gabapentin versus Lamotrigine monotherapy: A doubleblind comparison. Epilepsia 2000; 41 (Suppl): 138.
18. Viteri C, Verger K, Morralla C, Hernández G. Monet study: Gabapentin as monotherapy in 630 patients with partial seizures. Epilepsia 2000; 41 (Suppl): S69.
19. Appleton R, Fichtner K, LeMoreaux L, Alexander J, Halsall G, the Gabapentin Paediatric Study Group, et al. Gapapentin as ad-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study. Epilepsia 1999; 40: 1147-54.
20. Appleton R, Fichtner K, LeMoreaux L, Alexander J, Maton S, the Gabapentin Paediatric Study Group, et al. Gapapentin as ad-on therapy in children with refractory partial seizures: A 24-week, multicentre, open-label study. Dev Med Child Neurol 2001; 43: 269-73.
21. Khurana SD, Rivello J, Helmets S, Holmes G, Anderson J, Mikati MA. Efficacy of gabapentin therapy in children with refractory partial seizures. J Pediatr 1996; 128: 829-33.
22. Trudeau V, Myers S, LaMoreaux L, Anhut H, Garofalo E, Ebersole J. Gabapentin in naive childhood absence epilepsy: Results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996; 11: 470-5.
23. Padró LL, Rovira R. Gabapentina en monoterapia. Rev Neurol 1999; 29: 579-84.